Oxazepam description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Oxazepam

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

OXAZEPAM DESCRIPTION



Oxazepam





CLINICAL PHARMACOLOGY



PRECAUTIONS: Geriatric Use

ANIMAL PHARMACOLOGY & OR TOXICOLOGY









INDICATIONS & USAGE







OXAZEPAM CONTRAINDICATIONS



WARNINGS




Physical and Psychological Dependence


USE IN PREGNANCY
An increased risk of congenital malformations associated with the use of minor tranquilizers (chlordiazepoxide, diazepam, and meprobramate) during the first trimester of pregnancy has been suggested in several studies. Oxazepam, a benzodiazepine derivative, has not been studied adequately to determine whether it, too, may be associated with an increased risk of fetal abnormality. Because use of these drugs is rarely a matter of urgency, their use during this period should almost always be avoided. The possibility that a woman of childbearing potential may be pregnant at the time of institution of therapy should be considered. Patients should be advised that if they become pregnant during therapy or intend to become pregnant, they should communicate with their physician about the desirability of discontinuing the drug.


PRECAUTIONS

General


INFORMATION FOR PATIENTS



PEDIATRIC USE



GERIATRIC USE

CLINICAL PHARMACOLOGY
PRECAUTIONS: GeneralADVERSE REACTIONS). In general, dose selection for oxazepam for elderly patients should be cautious, usually starting at the lower end of the dosing range (seeDOSAGE AND ADMINISTRATION).

OXAZEPAM ADVERSE REACTIONS







OVERDOSAGE



Symptoms


Management



DOSAGE & ADMINISTRATION





HOW SUPPLIED


















REFERENCES



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Oxazepam

Oxazepam

Oxazepam

Oxazepam CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-715(NDC:0781-2809)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OXAZEPAM OXAZEPAM 10 mg

Inactive Ingredients

Ingredient Name Strength
BENZYL ALCOHOL
BUTYLPARABEN
STARCH, CORN
D&C RED NO. 7
lactose monohydrate
edetate calcium disodium
FERROSOFERRIC OXIDE
GELATIN
HYPROMELLOSE 2910 (3 MPA.S)
MAGNESIUM STEARATE
METHYLPARABEN
propylene glycol
PROPYLPARABEN
SHELLAC
SODIUM LAURYL SULFATE
sodium propionate
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
white 14 mm GG505 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-715-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA071813 2011-09-06


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.